Back to Journals » Neurobehavioral HIV Medicine » Volume 3

Cognitive reserve masks neurobehavioral expression of human immunodeficiency virus-associated neurological disorder in older patients

Authors Thames A, Foley, Panos S, Singer, El-Saden, Hinkin C

Published 31 October 2011 Volume 2011:3 Pages 87—93


Review by Single-blind

Peer reviewer comments 3

April D Thames1,3, Jessica M Foley2, Stella E Panos1,3, Elyse J Singer1, Suzie El-Saden1,3, Charles H Hinkin1,3
1University of California, Los Angeles School of Medicine, Los Angeles, CA; 2Boston VA Healthcare System/Harvard Medical School, Boston, MA; 3VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA

Background: Cognitive reserve theory may help to explain why some individuals are better able to withstand greater neurological insult before neurobehavioral manifestations occur. The present study provides a direct test of the cognitive reserve hypothesis in a sample particularly predisposed to cognitive impairment, ie, older human immunodeficiency virus (HIV)-positive adults.
Methods: Eighteen older HIV-positive adults, of mean (standard deviation) age 53.25 ± 4.2 years, with 13.5 ± 2.0 years of education, underwent magnetic resonance imaging and neuropsychological assessment. Regions of interest in the basal ganglia were extracted from T1 weighted scans and volumetric measurements were acquired. Cognitive reserve capacity was measured using premorbid intelligence quotient estimates and years of education. Participants were matched based on global neuropsychological performance.
Results: Individuals with higher levels of cognitive reserve demonstrated greater atrophy in the basal ganglia compared with individuals with lower levels of reserve, despite consistent cognitive function.
Conclusion: Older HIV-positive patients with higher levels of cognitive reserve may appear cognitively healthier than their striatal integrity would suggest.

Keywords: cognitive reserve, human immunodeficiency virus, magnetic resonance imaging, aging, basal ganglia

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Readers of this article also read:

Emerging and future therapies for hemophilia

Carr ME, Tortella BJ

Journal of Blood Medicine 2015, 6:245-255

Published Date: 3 September 2015

Acquired hemophilia A: emerging treatment options

Janbain M, Leissinger CA, Kruse-Jarres R

Journal of Blood Medicine 2015, 6:143-150

Published Date: 8 May 2015

Profile of efraloctocog alfa and its potential in the treatment of hemophilia A

George LA, Camire RM

Journal of Blood Medicine 2015, 6:131-141

Published Date: 24 April 2015

Second case report of successful electroconvulsive therapy for a patient with schizophrenia and severe hemophilia A

Saito N, Shioda K, Nisijima K, Kobayashi T, Kato S

Neuropsychiatric Disease and Treatment 2014, 10:865-867

Published Date: 16 May 2014

Managing hemophilia: the role of mobile technology

Khair K, Holland M

Smart Homecare Technology and TeleHealth 2014, 2:39-44

Published Date: 6 May 2014

Rituximab for managing acquired hemophilia A in a case of chronic neutrophilic leukemia with the JAK2 kinase V617F mutation

Imashuku S, Kudo N, Kubo K, Saigo K, Okuno N, Tohyama K

Journal of Blood Medicine 2012, 3:157-161

Published Date: 5 December 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

The use of PEGylated liposomes in the development of drug delivery applications for the treatment of hemophilia

Rivka Yatuv, Micah Robinson, Inbal Dayan-Tarshish, et al

International Journal of Nanomedicine 2010, 5:581-591

Published Date: 6 August 2010